Sunshine Biopharma cuts exercise price of outstanding Series B warrants to $1.22
SBFM•Series B warrant exercise price reset
Sunshine Biopharma reset the exercise price on its outstanding Series B Warrants to $1.22 following recent at-the-market share sales.
The revised exercise price remains subject to further adjustment under the Series B Warrant terms.
